- The high fecundity and rapid reproductive cycles of fish make them ideal candidates for accelerated gene function research, multi-generational validation, and high-throughput screening of genetic variations.
- Modern gene editing tools are used in aquaculture to enhance commercially valuable traits in fish, including growth rates, disease resistance, and environmental stress tolerance, enabling rapid development of high-yield fish varieties.
- The continued refinement and responsible deployment of gene editing tools are expected to contribute to the global availability of high-quality, sustainable protein sources from genetically improved fish.
Researchers from the Chinese Academy of Fishery Sciences, Xinjiang Agricultural University and Yazhoubay Agriculture and Aquaculture Development reviewed how modern genetic platforms could replace slow selective breeding methods with high-precision targeted modifications.
Their review provides an updated synthesis of embryo delivery strategies, molecular editing mechanisms and strict biosafety protocols.
Overcoming the slow pace of conventional selective breeding
The review addresses a mounting operational challenge facing global commercial food producers. While finfish farming continues to expand rapidly worldwide to satisfy rising nutritional and economic demands, conventional selective breeding programmes remain notoriously slow. Commercial fish producers rely on lengthy generations and face significant uncertainty when attempting to enhance valuable stock traits.
“Traditional breeding methods are plagued by limitations such as low precision and lengthy breeding cycles,” the study’s authors wrote. Conversely, gene editing technologies represented by the CRISPR/Cas system, base editing and prime editing have provided revolutionary tools for dissecting gene function, modelling human diseases, targeted trait improvement and ecological adaptation studies.
Tracking the industrial evolution of molecular tools
To explain how laboratories use these tools today, the researchers mapped the history of gene editing. Early scientific work relied on first-generation systems known as zinc-finger nucleases and transcription activator-like effector nucleases. These early tools used complex proteins to locate specific sections of genetic code before slicing cleanly through both strands of the DNA.
When programmable editing began, scientists used these protein systems alongside a specialised cutting enzyme called FokI to make the break. This combination made it much easier for researchers to carry out precise, targeted genetic changes.
Today, industrial laboratories favour ribonucleic acid-guided CRISPR systems. Because these platforms use simple guide molecules rather than complex engineered proteins, biotechnology suppliers can design genetic targets more easily and edit multiple distinct genes at the same time.
Delivering rapid results in commercial aquaculture production
For industrial breeders and commercial hatchery operators, the primary operational advantage of fish gene editing lies in the reproductive biology of aquatic species. Fish produce massive numbers of eggs and mature through short reproductive cycles compared with terrestrial livestock.
“Fishes exhibit high fecundity and short, rapid reproductive cycles, which represent one of the key factors facilitating accelerated gene function research, multi-generational genetic validation, and high-throughput screening,” the researchers stated.
This naturally high fertility allows commercial breeding facilities to test new genetic variations rapidly across subsequent generations. At the industrial aquaculture level, scientists use these precision tools to make targeted changes to specific genes that control physical growth rates and immune defences. By modifying these exact genomic locations, commercial suppliers can rapidly develop high-yield fish varieties that resist environmental stress and severe disease outbreaks.
Unlocking high-throughput pharmaceutical drug discovery
Beyond commercial seafood production, the scientific paper detailed major commercial opportunities for medical manufacturers and pharmaceutical discovery laboratories. Fish share many similar, or orthologous, genes with mammals.
This close biological relationship allows research facilities to study fundamental cellular processes across diverse scientific fields, including embryonic development, immunology, nervous system behaviour and metabolic function. According to the study’s authors, this makes them “widely utilised for human disease modelling and drug screening”.
By engineering fish genomes to mirror human genetic disorders or aquatic disease pathways, medical biotechnology companies can use aquatic models to screen new pharmaceutical drug candidates and identify novel therapeutic targets at industrial scale.
Advancing across four primary commercial operations
Throughout the review, the research team evaluated practical delivery strategies for inserting editing tools directly into developing fish embryos. By comparing these microinjection and embryo delivery methods, the study mapped major technical breakthroughs across four distinct operational areas.
First, research laboratories use targeted gene knockouts and insertions to verify fundamental cellular functions and understand the molecular mechanics of fish development and reproduction. Second, commercial hatcheries apply these tools directly to aquaculture breeding programmes to enhance commercial yields.
Third, producers use targeted edits to regulate colouration in high-value ornamental fish species. Finally, biomedical suppliers generate precise genetic mutants to build living human disease models.
Balancing commercial innovation with strict biosafety protocols
Despite the rapid technical progress, the researchers warned industrial biotechnology suppliers that advanced molecular tools carry substantial operational responsibilities. Moving gene-edited aquatic animals from laboratory test tanks into large-scale commercial farm production requires careful management to protect surrounding natural ecosystems.
“Gene editing technologies also raise significant concerns across biosafety, ethical, and regulatory domains,” the team cautioned. “Their development must proceed in tandem with robust risk assessment frameworks to advance sustainable aquaculture and environmental protection.”
To conclude their review, the researchers advised that a balance should be “struck between innovation and safety to provide strategic support for the construction of the Blue Granary”. They added: “Only by achieving a verifiable balance between innovation-driven development and ecological protection can fish gene editing truly become a green revolutionary force promoting high-quality aquaculture development, ensuring food security, and conserving biodiversity.”
“In the future, more genetically improved high-performance fish varieties will appear on dining tables worldwide, providing humans with higher-quality and sustainable protein sources.”
Source: Animals
“Advances in Fish Gene Editing”
https://doi.org/10.3390/ani16121874
Authors: Xu Jiaqing, et al
